Pro-Apoptosis, mTOR Pathways: New Targets for Lymphoma

AudioMedica News

Pro-Apoptosis, mTOR Pathways: New Targets for Lymphoma

Play Episode Pause Episode

Mute/Unmute Episode Rewind 10 Seconds 1x Fast Forward 30 seconds

00:00 /

RSS Feed

Share

Link

Embed

Owen O’Connor

Owen O’Connor, Memorial Sloan-Kettering Cancer Center, New York
Owen O’Connor also gave data from early, two studies: one looking at treating lymphoma with the drug SAHA which targets BCL-6 in the tumor preventing it’s anti-apoptotic influence; the other targeting the mTOR signaling pathway with a drug called temsirolimus.

[audio:https://www.audiomedica.com/podcasting/ash2005/Owen_O_Connor_2.mp3]

Click here for all the interviews from ASH 2005